Logo image of FRE.DE

FRESENIUS SE & CO KGAA (FRE.DE) Stock Fundamental Analysis

FRA:FRE - Deutsche Boerse Ag - DE0005785604 - Common Stock - Currency: EUR

43.8  +0.06 (+0.14%)

Fundamental Rating

4

Taking everything into account, FRE scores 4 out of 10 in our fundamental rating. FRE was compared to 26 industry peers in the Health Care Providers & Services industry. FRE has only an average score on both its financial health and profitability. FRE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year FRE was profitable.
FRE had a positive operating cash flow in the past year.
FRE had positive earnings in 4 of the past 5 years.
FRE had a positive operating cash flow in each of the past 5 years.
FRE.DE Yearly Net Income VS EBIT VS OCF VS FCFFRE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

The Return On Assets of FRE (0.98%) is worse than 69.23% of its industry peers.
With a Return On Equity value of 2.17%, FRE is not doing good in the industry: 73.08% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 2.69%, FRE is doing worse than 69.23% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for FRE is below the industry average of 5.58%.
The 3 year average ROIC (1.83%) for FRE is below the current ROIC(2.69%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.98%
ROE 2.17%
ROIC 2.69%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
FRE.DE Yearly ROA, ROE, ROICFRE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

FRE's Profit Margin of 1.91% is in line compared to the rest of the industry. FRE outperforms 42.31% of its industry peers.
In the last couple of years the Profit Margin of FRE has declined.
FRE's Operating Margin of 8.68% is amongst the best of the industry. FRE outperforms 80.77% of its industry peers.
In the last couple of years the Operating Margin of FRE has declined.
FRE's Gross Margin of 24.48% is in line compared to the rest of the industry. FRE outperforms 46.15% of its industry peers.
FRE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.68%
PM (TTM) 1.91%
GM 24.48%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
FRE.DE Yearly Profit, Operating, Gross MarginsFRE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

FRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, FRE has about the same amount of shares outstanding.
Compared to 5 years ago, FRE has more shares outstanding
FRE has a better debt/assets ratio than last year.
FRE.DE Yearly Shares OutstandingFRE.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
FRE.DE Yearly Total Debt VS Total AssetsFRE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

FRE has an Altman-Z score of 1.98. This is not the best score and indicates that FRE is in the grey zone with still only limited risk for bankruptcy at the moment.
FRE's Altman-Z score of 1.98 is in line compared to the rest of the industry. FRE outperforms 57.69% of its industry peers.
The Debt to FCF ratio of FRE is 8.76, which is on the high side as it means it would take FRE, 8.76 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.76, FRE is in line with its industry, outperforming 53.85% of the companies in the same industry.
FRE has a Debt/Equity ratio of 0.62. This is a neutral value indicating FRE is somewhat dependend on debt financing.
FRE's Debt to Equity ratio of 0.62 is fine compared to the rest of the industry. FRE outperforms 76.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 8.76
Altman-Z 1.98
ROIC/WACC0.53
WACC5.03%
FRE.DE Yearly LT Debt VS Equity VS FCFFRE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 1.43 indicates that FRE should not have too much problems paying its short term obligations.
FRE's Current ratio of 1.43 is fine compared to the rest of the industry. FRE outperforms 65.38% of its industry peers.
FRE has a Quick Ratio of 1.11. This is a normal value and indicates that FRE is financially healthy and should not expect problems in meeting its short term obligations.
FRE's Quick ratio of 1.11 is fine compared to the rest of the industry. FRE outperforms 73.08% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.11
FRE.DE Yearly Current Assets VS Current LiabilitesFRE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 893.08% over the past year.
FRE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.29% yearly.
Looking at the last year, FRE shows a small growth in Revenue. The Revenue has grown by 3.64% in the last year.
FRE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.22% yearly.
EPS 1Y (TTM)893.08%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%-74.42%
Revenue 1Y (TTM)3.64%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%0.11%

3.2 Future

The Earnings Per Share is expected to grow by 10.10% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.98% on average over the next years.
EPS Next Y10.09%
EPS Next 2Y10.97%
EPS Next 3Y9.91%
EPS Next 5Y10.1%
Revenue Next Year4.88%
Revenue Next 2Y4.93%
Revenue Next 3Y4.9%
Revenue Next 5Y4.98%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FRE.DE Yearly Revenue VS EstimatesFRE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10B 20B 30B 40B
FRE.DE Yearly EPS VS EstimatesFRE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.72 indicates a correct valuation of FRE.
Based on the Price/Earnings ratio, FRE is valued a bit cheaper than the industry average as 61.54% of the companies are valued more expensively.
FRE is valuated rather cheaply when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
FRE is valuated reasonably with a Price/Forward Earnings ratio of 11.82.
Based on the Price/Forward Earnings ratio, FRE is valued a bit cheaper than the industry average as 61.54% of the companies are valued more expensively.
FRE is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.09, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.72
Fwd PE 11.82
FRE.DE Price Earnings VS Forward Price EarningsFRE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

FRE's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of FRE indicates a slightly more expensive valuation: FRE is more expensive than 69.23% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.88
EV/EBITDA 10.36
FRE.DE Per share dataFRE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

FRE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.66
PEG (5Y)N/A
EPS Next 2Y10.97%
EPS Next 3Y9.91%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.37%, FRE has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.00, FRE pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, FRE has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.37%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
FRE.DE Yearly Dividends per shareFRE.DE Yearly Dividends per shareYearly Dividends per share 2015 2016 2019 2020 2021 2022 2023 2025 0.5 1 1.5

5.3 Sustainability

22.75% of the earnings are spent on dividend by FRE. This is a low number and sustainable payout ratio.
DP22.75%
EPS Next 2Y10.97%
EPS Next 3Y9.91%
FRE.DE Yearly Income VS Free CF VS DividendFRE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B
FRE.DE Dividend Payout.FRE.DE Dividend Payout, showing the Payout Ratio.FRE.DE Dividend Payout.PayoutRetained Earnings

FRESENIUS SE & CO KGAA

FRA:FRE (8/11/2025, 5:36:15 PM)

43.8

+0.06 (+0.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-05 2025-11-05
Inst Owners36.44%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap24.67B
Analysts83.48
Price Target49.44 (12.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.37%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP22.75%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.13%
Min EPS beat(2)12.64%
Max EPS beat(2)17.61%
EPS beat(4)3
Avg EPS beat(4)8.93%
Min EPS beat(4)-3.48%
Max EPS beat(4)17.61%
EPS beat(8)4
Avg EPS beat(8)-53.43%
EPS beat(12)5
Avg EPS beat(12)-43.42%
EPS beat(16)8
Avg EPS beat(16)-32.16%
Revenue beat(2)2
Avg Revenue beat(2)2.62%
Min Revenue beat(2)2.4%
Max Revenue beat(2)2.84%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)2.84%
Revenue beat(8)3
Avg Revenue beat(8)-0.09%
Revenue beat(12)4
Avg Revenue beat(12)-0.24%
Revenue beat(16)6
Avg Revenue beat(16)-0.01%
PT rev (1m)-0.06%
PT rev (3m)5.91%
EPS NQ rev (1m)5.46%
EPS NQ rev (3m)-0.47%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.16%
Revenue NQ rev (3m)-0.69%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.07%
Valuation
Industry RankSector Rank
PE 16.72
Fwd PE 11.82
P/S 1.12
P/FCF 15.88
P/OCF 10.03
P/B 1.27
P/tB 11.43
EV/EBITDA 10.36
EPS(TTM)2.62
EY5.98%
EPS(NY)3.71
Fwd EY8.46%
FCF(TTM)2.76
FCFY6.3%
OCF(TTM)4.37
OCFY9.97%
SpS39.25
BVpS34.46
TBVpS3.83
PEG (NY)1.66
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.98%
ROE 2.17%
ROCE 5.5%
ROIC 2.69%
ROICexc 3.02%
ROICexgc 6.65%
OM 8.68%
PM (TTM) 1.91%
GM 24.48%
FCFM 7.03%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
ROICexc(3y)1.84%
ROICexc(5y)2.65%
ROICexgc(3y)3.69%
ROICexgc(5y)5.83%
ROCE(3y)3.71%
ROCE(5y)5.33%
ROICexcg growth 3Y-17.75%
ROICexcg growth 5Y-15.4%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y-11.09%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score7
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 8.76
Debt/EBITDA 3.91
Cap/Depr 77.02%
Cap/Sales 4.09%
Interest Coverage 4.28
Cash Conversion 79.5%
Profit Quality 368.25%
Current Ratio 1.43
Quick Ratio 1.11
Altman-Z 1.98
F-Score7
WACC5.03%
ROIC/WACC0.53
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)893.08%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%-74.42%
EPS Next Y10.09%
EPS Next 2Y10.97%
EPS Next 3Y9.91%
EPS Next 5Y10.1%
Revenue 1Y (TTM)3.64%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%0.11%
Revenue Next Year4.88%
Revenue Next 2Y4.93%
Revenue Next 3Y4.9%
Revenue Next 5Y4.98%
EBIT growth 1Y9.47%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year65.74%
EBIT Next 3Y23.83%
EBIT Next 5Y16.02%
FCF growth 1Y-34.12%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-42.44%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%